Denali Therapeutics (NASDAQ:DNLI – Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.68) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.51) by ($0.17), FiscalAI reports. The firm had revenue of $3.60 million during the quarter, compared to analyst estimates of $2.15 million. During the same period [...]
Earnings tickerreport Aug 8, 2026